US Bancorp’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,474
| Closed | -$4.48K | – | 4390 |
|
2024
Q4 | $4.48K | Sell |
1,474
-471
| -24% | -$1.43K | ﹤0.01% | 3670 |
|
2024
Q3 | $10.1K | Buy |
1,945
+175
| +10% | +$908 | ﹤0.01% | 3356 |
|
2024
Q2 | $4.55K | Sell |
1,770
-1,232
| -41% | -$3.17K | ﹤0.01% | 3533 |
|
2024
Q1 | $14.8K | Buy |
3,002
+573
| +24% | +$2.82K | ﹤0.01% | 3195 |
|
2023
Q4 | $21.4K | Sell |
2,429
-846
| -26% | -$7.44K | ﹤0.01% | 3018 |
|
2023
Q3 | $37.6K | Buy |
3,275
+60
| +2% | +$688 | ﹤0.01% | 2578 |
|
2023
Q2 | $81.4K | Sell |
3,215
-763
| -19% | -$19.3K | ﹤0.01% | 2268 |
|
2023
Q1 | $128K | Sell |
3,978
-22,403
| -85% | -$722K | ﹤0.01% | 2074 |
|
2022
Q4 | $487K | Buy |
26,381
+9,382
| +55% | +$173K | ﹤0.01% | 1411 |
|
2022
Q3 | $458K | Buy |
16,999
+16,147
| +1,895% | +$435K | ﹤0.01% | 1429 |
|
2022
Q2 | $12K | Sell |
852
-1,254
| -60% | -$17.7K | ﹤0.01% | 3305 |
|
2022
Q1 | $41K | Sell |
2,106
-425
| -17% | -$8.27K | ﹤0.01% | 2719 |
|
2021
Q4 | $41K | Buy |
2,531
+2,256
| +820% | +$36.5K | ﹤0.01% | 2744 |
|
2021
Q3 | $8K | Hold |
275
| – | – | ﹤0.01% | 3507 |
|
2021
Q2 | $8K | Hold |
275
| – | – | ﹤0.01% | 3481 |
|
2021
Q1 | $8K | Buy |
275
+18
| +7% | +$524 | ﹤0.01% | 3364 |
|
2020
Q4 | $7K | Hold |
257
| – | – | ﹤0.01% | 3296 |
|
2020
Q3 | $6K | Hold |
257
| – | – | ﹤0.01% | 3203 |
|
2020
Q2 | $6K | Buy |
257
+59
| +30% | +$1.38K | ﹤0.01% | 3204 |
|
2020
Q1 | $3K | Hold |
198
| – | – | ﹤0.01% | 3333 |
|
2019
Q4 | $3K | Sell |
198
-545
| -73% | -$8.26K | ﹤0.01% | 3369 |
|
2019
Q3 | $10K | Buy |
743
+198
| +36% | +$2.67K | ﹤0.01% | 3061 |
|
2019
Q2 | $7K | Sell |
545
-128
| -19% | -$1.64K | ﹤0.01% | 3212 |
|
2019
Q1 | $11K | Buy |
673
+173
| +35% | +$2.83K | ﹤0.01% | 3041 |
|
2018
Q4 | $10K | Sell |
500
-260
| -34% | -$5.2K | ﹤0.01% | 3043 |
|
2018
Q3 | $19K | Hold |
760
| – | – | ﹤0.01% | 2946 |
|
2018
Q2 | $21K | Buy |
760
+260
| +52% | +$7.18K | ﹤0.01% | 2924 |
|
2018
Q1 | $15K | Buy |
+500
| New | +$15K | ﹤0.01% | 3042 |
|